Production (Stage)
Kezar Life Sciences, Inc.
KZR
$4.43
$0.030.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -36.39% | -34.33% | -32.00% | -30.60% | -30.22% |
| Total Receivables | -28.02% | -81.49% | -84.44% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -22.15% | -10.67% | -67.00% | -87.19% | -84.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 70.61% | 80.33% | 483.74% | 5.36% | 123.29% |
| Total Current Assets | -35.18% | -33.56% | -32.16% | -31.16% | -30.02% |
|
|
|||||
| Total Current Assets | -35.18% | -33.56% | -32.16% | -31.16% | -30.02% |
| Net Property, Plant & Equipment | -46.76% | -45.01% | -57.58% | -56.57% | -42.16% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -87.75% | -56.84% | -61.88% | -0.61% | 8.12% |
| Total Assets | -37.10% | -34.60% | -34.19% | -31.69% | -29.93% |
|
|
|||||
| Total Accounts Payable | -61.14% | -55.75% | 10.93% | -9.19% | 22.32% |
| Total Accrued Expenses | -8.24% | 22.43% | -9.32% | 10.63% | -2.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 100.14% | 190.27% | 152.30% | 110.96% | 66.09% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.96% | 14.57% | 22.53% | 27.36% | 18.45% |
|
|
|||||
| Total Current Liabilities | 4.96% | 14.57% | 22.53% | 27.36% | 18.45% |
| Long-Term Debt | -56.12% | -49.24% | -36.57% | -23.74% | -10.76% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -73.02% | -60.25% | -50.99% | -43.99% | -38.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -26.05% | -17.52% | -9.89% | -6.00% | -5.30% |
|
|
|||||
| Common Stock & APIC | 2.30% | 2.44% | 2.44% | 3.13% | 3.39% |
| Retained Earnings | -21.11% | -23.87% | -30.07% | -33.37% | -37.38% |
| Treasury Stock & Other | 34.65% | -24.62% | 115.57% | 53.61% | 32.12% |
| Total Common Equity | -39.06% | -37.67% | -37.94% | -35.13% | -33.02% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -39.06% | -37.67% | -37.94% | -35.13% | -33.02% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -39.06% | -37.67% | -37.94% | -35.13% | -33.02% |
|
|
|||||